KCNMA1

KCNMA1, also known as potassium channel, subfamily M, alpha subunit 1, is a gene located on chromosome 19q13.3. It encodes a protein that is a subunit of voltage-gated potassium channels, which play a crucial role in regulating the electrical activity of cells. These channels are essential for maintaining the resting membrane potential and controlling the duration and shape of action potentials in various cell types, including neurons, muscle cells, and cardiac cells.

Mutations in the KCNMA1 gene have been associated with several genetic disorders, including familial hemiplegic migraine type 1 (FHM1), episodic ataxia type 2 (EA2), and familial hemiplegic migraine type 2 (FHM2). These disorders are characterized by recurrent attacks of headache, often accompanied by neurological symptoms such as weakness, numbness, or loss of coordination.

The KCNMA1 protein is a pore-forming subunit of the voltage-gated potassium channel, which consists of four subunits arranged in a tetrameric structure. The pore-forming subunit is responsible for the selective permeability of the channel to potassium ions. The channel is activated by depolarization of the membrane potential, leading to the opening of the pore and the efflux of potassium ions, which helps to repolarize the membrane and terminate the action potential.

In summary, KCNMA1 is a gene that encodes a protein involved in the regulation of cellular electrical activity. Mutations in this gene can lead to various genetic disorders characterized by recurrent neurological symptoms. The protein encoded by KCNMA1 is a subunit of voltage-gated potassium channels, which are essential for maintaining the resting membrane potential and controlling the duration and shape of action potentials in various cell types.